# Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease

> **NCT07426250** · — · NOT_YET_RECRUITING · sponsor: **Aarhus University Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Oligometastatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07426250
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2030-03-01
- **Final completion:** 2030-09-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07426250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07426250, "Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07426250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*